Human herpesvirus 6 reactivation and drug-induced hypersensitivity syndrome

References

• Tohyama M, Hashimoto K, Yasukawa M et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br. J. Dermatol.157, 934–940 (2007).
   PubMed Web of Science ®Google Scholar
• Descamps V, Mahe E, Ranger-Rogez S. Systemic reactions to HHV6 infection. In: Perspective in Medical Virology. Krueger G, Ablashi D (Eds). Elsevier, 151–165 (2006).
   Google Scholar
• Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol.156, 1083–1084 (2007).
   PubMed Web of Science ®Google Scholar
• Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N. Engl. J. Med.242, 897–898 (1950).
   PubMed Web of Science ®Google Scholar
• Schreiber MM, McGregor JG. Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs. Arch. Dermatol.97, 297–300 (1968).
   PubMed Web of Science ®Google Scholar
• Begon E, Roujeau JC. Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann. Dermatol. Venereol.131, 293–297 (2004).
   PubMed Web of Science ®Google Scholar
• Descamps V, Bouscarat F, Laglenne S et al.Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br. J. Dermatol.137, 605–608 (1997).
   PubMedGoogle Scholar
• Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch. Dermatol.134, 1108–1112 (1998).
   PubMedGoogle Scholar
• Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol.134, 1113–1117 (1998).
   PubMedGoogle Scholar
• Descamps V, Valance A, Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol.137, 301–304 (2001).
   PubMed Web of Science ®Google Scholar
• Sekine N, Motokura T, Oki T et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA285, 1153–1154 (2001).
   Google Scholar
• Descamps V, Collot S, Houhou N, Ranger-Rogez S. Human herpesvirus-6 encephalitis associated with hypersensitivity syndrome. Ann. Neurol..53, 280 (2003).
   Google Scholar
• Fujino Y, Nakajima M, Inoue H, Kusuhara T, Yamada T. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann. Neurol.51, 771–774 (2002).
   PubMed Web of Science ®Google Scholar
• Descamps V, Collot S, Mahe E, Houhou N, Crickx B, Ranger-Rogez S. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. J. Invest. Dermatol.121, 215–216 (2003).
   Google Scholar
• Descamps V, Mahe E, Houhou N et al. Drug-induced hypersensitivity syndrome associated with Epstein–Barr virus infection. Br. J. Dermatol.148, 1032–1034 (2003).
   Google Scholar
• Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J. Dermatol.32, 278–281 (2005).
   Google Scholar
• Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br. J. Dermatol.155, 344–349 (2006).
   PubMed Web of Science ®Google Scholar
• Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br. J. Dermatol..149, 165–169 (2003).
   PubMed Web of Science ®Google Scholar
• Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol.140, 183–188 (2004).
   PubMedGoogle Scholar
• Boccara O, Valeyrie-Allanore L, Crickx B, Descamps V. Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Eur. J. Dermatol.16, 666–668 (2006).
   Google Scholar
• Takahashi H, Tanaka M, Tanikawa A et al. A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus. Clin. Exp. Dermatol.31, 33–35 (2006).
   Google Scholar
• Mardivirin L, Lacroix A, Delebassée S, Descamps V, Ranger-Rogez S. Augmentation de la réplication in vitro de l’herpèsvirus humain 6 en présence de valproate de sodium. Virologie11, 1–3 (2007).
   Google Scholar